Three Levels of Disease Modification with SGLT-2 Inhibitors: Holy Grail in Vasculopathy

SGLT2 inhibitors have an insulin-independent mechanism of action leading to increasing glycosuria and lowering plasma glucose concentration, which results in cardiovascular and renal benefits shown in various studies. Other benefits include improvements in hyperglycemia, decreased fluid retention, r...

Full description

Bibliographic Details
Main Author: Archit Dhaiya; Rajeev Sharma; Nagendra Bhoopathy; Rajeev Agarwal
Format: Article
Language:English
Published: Sonali Sharma on behalf of Rajasthan University of Health Sciences 2023-07-01
Series:RUHS Journal of Health Sciences
Subjects:
Online Access:https://ruhsjhs.in/articleDetails.php?artid=TXprPQ==